Kamala Harris‘ address at the Democratic National Convention (DNC) significantly outperformed performed Donald Trump‘s speech at the Republican National Convention (RNC) by a whopping 22% in TV ratings.
What Happened: The ratings data, which combined viewership from seven networks, revealed that Harris’ speech scored a rating of 15, while Trump’s address trailed behind with a rating of 12.3.
Also Read: Kamala Harris And Donald Trump Clash Over Federal Reserve's Autonomy
Industry research firm Nielsen disclosed that the final night of the DNC averaged 26.2 million viewers across 15 networks, with Harris’ speech alone pulling in 28.9 million viewers. This made the fourth night of the convention the most viewed, with viewership increasing by 30% from the previous nights.
Trump, who is known for his fixation with ratings, had earlier predicted that the RNC’s viewership numbers would be unsurpassable by the DNC. However, the DNC outpaced the RNC’s viewership totals for each day of the conventions.
Read Also
Lawmakers Made Huge Investments This Year. Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool
Adding to Trump’s disappointment, the top market for Harris’ speech on the final day was reported to be West Palm Beach, Florida, located adjacent to his Mar-a-Lago estate.
Why It Matters: The higher viewership for Harris’ speech not only signifies her popularity but also indicates a potential shift in public sentiment towards the Democratic party. The fact that the top market for Harris’ speech was West Palm Beach, Florida, a location close to Trump’s estate, could be seen as a symbolic victory for the Democrats.
These ratings could also be a reflection of the public’s interest and engagement in the upcoming elections.
With the DNC outperforming the RNC in viewership for each day of the conventions, it suggests that the public is keenly following the political discourse and is invested in the election process.
Read Next:
This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.